Insider · CIK 0001927715
Anastasios Aslidis
Files at ESEA (EUROSEAS LTD.), COSM (Cosmos Health Inc.), EDRY (EuroDry Ltd.). First filing Apr 16, 2026, latest Oct 5, 2026.
Anastasios Aslidis files SEC Form 4 as CFO and director at ESEA (EUROSEAS LTD.), and also at EDRY (EuroDry Ltd.), COSM (Cosmos Health Inc.). Since Apr 16, 2026, Anastasios Aslidis has reported 1 open-market buy worth $71k and 2 open-market sells worth $524k, the latest filed on Oct 5, 2026.
A track record needs three past buys with six months of prices behind them; Anastasios Aslidis has 0, so none is measured yet.
The newest scored trade: sold $166k of EDRY on Oct 1, 2026, filed Oct 5, 2026, scored 33 (weak). In the last 12 months: 1 buy worth $71k and 2 sells worth $524k.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
ESEA: EUROSEAS LTD.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
EDRY: EuroDry Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | EDRYsell EuroDry Ltd. | $166k 3,000 shares | -6% | +362% from low-22% from high | |
| 42Moderate | ESEAsell EUROSEAS LTD. | $357k 5,000 shares | -19% | +39% from low-10% from high | |
| 30Weak | ESEAbuy EUROSEAS LTD. | $71k 1,000 shares | +4% | +160% from low-1% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 2, 2026 | ESEA EUROSEAS LTD. | 6,350 0.09% of outstanding | $445k | Mar 2, 2026 | $47k |
| Aug 20, 2025 | ESEA EUROSEAS LTD. | 9,300 0.13% of outstanding | $550k | Aug 20, 2025 | $47k |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | EDRY EuroDry Ltd. | SOpen-market sale Common stock | -3,000 | $55.40 | $166k | 46,150 | 8 d ago |
| Oct 1, 2026 | ESEA EUROSEAS LTD. | SOpen-market sale Common stock | -4,000 | $71.31 | $285k | 21,910 | 8 d ago |
| Oct 2, 2026 | ESEA EUROSEAS LTD. | SOpen-market sale Common stock | -1,000 | $72.10 | $72k | 20,910 | 8 d ago |
| May 19, 2026 | COSM Cosmos Health Inc. | AGrant or award Common Stock, par value $.001 | +40,000 | $0.28 | $11k | 100,000 | Jun 11, 2026 |
| May 19, 2026 | COSM Cosmos Health Inc. | CConversion Restricted Stock Unitderivative | -40,000 | $0.00 | $0 | 0 | Jun 11, 2026 |
| Apr 14, 2026 | ESEA EUROSEAS LTD. | POpen-market purchase Common Stock | -1,000 | $70.82 | $71k | 25,910 | Apr 16, 2026 |
Questions about Anastasios Aslidis
Answered from the filings on this page, as of the latest one.
Is Anastasios Aslidis buying or selling?
In the last 12 months Anastasios Aslidis reported 1 open-market buy worth $71k and 2 open-market sells worth $524k on SEC Form 4; the latest was sold $166k of EDRY on Oct 1, 2026. Grants, option exercises and tax withholding are not counted.
How did Anastasios Aslidis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anastasios Aslidis has 0.
Where does Anastasios Aslidis file Form 4?
Anastasios Aslidis has filed Form 4 at ESEA (EUROSEAS LTD.) as Chief Financial Officer; EDRY (EuroDry Ltd.) as Chief Financial Officer; COSM (Cosmos Health Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.